You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 29, 2024

~ Buy the JANUVIA (sitagliptin phosphate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR JANUVIA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for januvia

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00086502 ↗	Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus	Completed	Merck Sharp & Dohme Corp.	Phase 3	2004-06-01	The purpose of this study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00086515 ↗	Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2004-06-30	The purpose of this study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00087516 ↗	Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2004-06-01	The purpose of this clinical study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00289848 ↗	MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-03-01	This is a clinical study to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00337610 ↗	Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-06-01	A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic (blood sugar) control on metformin therapy.
NCT00350779 ↗	Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-06-12	A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin/peroxisome proliferator-activated receptor gamma (PPARg) agonist combination therapy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for januvia

Condition Name

Chart
Table

Condition Name for januvia
Intervention	Trials
Type 2 Diabetes Mellitus	41
Type 2 Diabetes	32
Diabetes Mellitus, Type 2	13
Type 1 Diabetes	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for januvia
Intervention	Trials
Diabetes Mellitus	97
Diabetes Mellitus, Type 2	90
Diabetes Mellitus, Type 1	12
Hyperglycemia	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for januvia

Trials by Country

Map
Table

Trials by Country for januvia
Location	Trials
United States	249
Italy	13
Canada	13
Korea, Republic of	12
Mexico	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for januvia
Location	Trials
Texas	17
Ohio	14
California	14
Florida	13
Georgia	13
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for januvia

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for januvia
Clinical Trial Phase	Trials
Phase 4	63
Phase 3	36
Phase 2/Phase 3	2
[disabled in preview]	34
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for januvia
Clinical Trial Phase	Trials
Completed	124
Terminated	13
Unknown status	11
[disabled in preview]	13
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for januvia

Sponsor Name

Chart
Table

Sponsor Name for januvia
Sponsor	Trials
Merck Sharp & Dohme Corp.	53
Emory University	7
AstraZeneca	6
[disabled in preview]	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for januvia
Sponsor	Trials
Other	135
Industry	100
NIH	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.